Literature DB >> 17720860

VIP inhibits P. gingivalis LPS-induced IL-18 and IL-18BPa in monocytes.

N Foster1, K Andreadou, L Jamieson, P M Preshaw, J J Taylor.   

Abstract

IL-18 is a pro-inflammatory cytokine that is important in the regulation of T-cells and is elevated in inflammatory disorders such as periodontal disease. Vasoactive intestinal peptide (VIP) modulates immune responses to the periodontal pathogen Porphyromonas gingivalis (Pg). Our objective was to investigate the effect of Pg LPS on IL-18 and its natural inhibitor, IL-18 binding protein (IL-18BPa), in human monocytes, and the effect of VIP on this system. We demonstrated that Pg LPS induced both IL-18 and IL-18BPa secretion in cultures of the human monocytic cell line THP-1, as measured by specific ELISA. The addition of antibodies to IL-18BPa to the stimulated THP-1 cultures resulted in increased levels of free IL-18, indicating a specific interaction between IL18 and IL-18BPa in this system. VIP (10(-8)M) inhibited both IL-18 and IL-18Bpa secretion by stimulated monocytes. We conclude that IL-18 and IL-18BPa secretion by monocytes is part of the immune response to Pg, and that VIP can inhibit this process.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17720860     DOI: 10.1177/154405910708600915

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  5 in total

1.  Anti-inflammatory effect of 1,25-dihydroxyvitamin D3 is associated with crosstalk between signal transducer and activator of transcription 5 and the vitamin D receptor in human monocytes.

Authors:  Mengxue Yang; B O Yang; Hua Gan; Xianwen Li; Jie Xu; Jie Yu; Lin Gao; Fengping Li
Journal:  Exp Ther Med       Date:  2015-03-02       Impact factor: 2.447

2.  Effects of 1,25-(OH)(2)D (3) on the expressions of vitamin D receptor, STAT5 and cytoskeletal rearrangement in human monocytes incubated with sera from type 2 diabetes patients and diabetic nephropathy patients with uremia.

Authors:  Mengxue Yang; Zhaonan Shen; Danyan Chen; Hua Gan; Qing Shen; Bo Yang; XiaoGang Du
Journal:  Inflamm Res       Date:  2012-02-10       Impact factor: 4.575

Review 3.  Immunomodulation of innate immune responses by vasoactive intestinal peptide (VIP): its therapeutic potential in inflammatory disease.

Authors:  S G R Smalley; P A Barrow; N Foster
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

4.  Differential expression of immunoregulatory genes in monocytes in response to Porphyromonas gingivalis and Escherichia coli lipopolysaccharide.

Authors:  H E Barksby; C J Nile; K M Jaedicke; J J Taylor; P M Preshaw
Journal:  Clin Exp Immunol       Date:  2009-06       Impact factor: 4.330

5.  IL18 Polymorphism and Periodontitis Susceptibility, Regardless of IL12B, MMP9, and Smoking Habits.

Authors:  Patrícia Yumeko Tsuneto; Victor Hugo de Souza; Josiane Bazzo de Alencar; Joana Maira Valentini Zacarias; Cléverson O Silva; Jeane Eliete Laguila Visentainer; Ana Maria Sell
Journal:  Mediators Inflamm       Date:  2019-04-01       Impact factor: 4.711

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.